Comprehensive labs
Broad Quest and LabCorp panels at wholesale; you set retail and keep the margin.
Programs
A premium longevity program, owned by your brand
Combine deep bloodwork, a genetic pathway report, and provider-guided protocols into your highest tier. Licensed providers own every clinical decision.
$0 to start$0 until you're liveno cardcancel anytime
WellStaq is a white-label telehealth platform that lets longevity connect bloodwork, licensed doctor consultations, eligible 503A pharmacy services, and optional supplements under their own brand. Independent clinicians control care; compounded drugs are not FDA-approved.
A recognizable model. Your own brand.
Build the Ro and Hims of longevity — and own it
Think Function Health-style lab memberships and Hims-style access to care, brought together under your own brand. Start with bloodwork, connect members with a licensed doctor, then support appropriate next steps. These are business-model references, not affiliations; services and results differ.
The model members recognize
- Online telehealth visits at scale
- Provider-guided follow-up when appropriate
- Branded supplements and monthly memberships
Familiar access to care, with transparent clinical roles.
Your version
Bloodwork first. Your brand throughout.
- White-label telehealth and eligible 503A pharmacy pathways
- + blood labs and genetic reports
- + your brand and connected member experience
- + optional supplements and your own coaching
Launch in weeks, for a flat fee — no raise required.
Your premium tier, built on data
Longevity-minded members want a comprehensive, data-rich experience and are willing to invest in it, which makes this a natural premium tier. Wellstaq pairs extensive labs with a genetic pathway report and provider-guided protocols, all under your brand, while an independent, board-certified network licensed in all 50 states owns every clinical decision. Commercial pricing and clinical billing follow separate lawful arrangements; the platform is a flat $997/mo, wholesale pass-through, zero percent of your sales.
14 pathways in the genetic report
What ships with the program
Genetic pathway report
A one-time report mapping variants to pathways as a roadmap to discuss with a provider; you set retail.
Unified health data
Blood and DNA combined in your branded app to inform provider review.
Independent provider network
Licensed clinicians in all 50 states owning all evaluation and any prescribing.
Telehealth consults
Clinical fees and pharmacy charges follow separate lawful billing arrangements; any management fees require state-specific review. WellStaq does not promise prescription commissions.
Supplement line
White-label supplements at wholesale; you set retail and keep the margin.
How the program comes together
-
01
Deep baseline
Members complete comprehensive labs and the genetic pathway report through your brand.
-
02
Provider-guided review
A licensed provider reviews the unified data and owns any protocol or prescribing decision.
-
03
Ongoing protocol
The provider sets a follow-up cadence; results, supplements, and check-ins live in your app.
Premium
positioning vs. single-service offers
A bundled, data-driven program supports a higher price point than one-off services while keeping the clinical work, and the liability, with the network.
Three paths — and why partners pick Wellstaq
You're really choosing between sending patients to someone else's brand, building it all yourself, or owning the model on Wellstaq.
Refer out to Function Health, Ro & Hims
- You lose the patient to their brand
- $0 recurring revenue to you
- The member experience carries their brand
- Services and availability vary by provider
Build it yourself
- Build and maintain your own technology
- Arrange clinical, privacy, and legal support
- You vet compounders and track 50-state rules
- You build labs, pharmacy, app and supplements
Build it on Wellstaq
- Patients stay under your brand
- Recurring revenue you keep — flat $997/mo, live in weeks
- An independent 50-state network owns clinical + prescribing
- Labs, genetics, telehealth, 503A Rx and supplements — not just longevity
- Earn from lawful products and nonclinical services; clinical billing stays separate
How the economics work
One platform fee. Build value beyond the test.
Standard $997/mo. First 100 Early Adopters: $297/mo with a lifetime price lock. Save $700/month — $8,400 every year on platform access. Lead with bloodwork, connect members with licensed telehealth and eligible 503A pharmacy services, and offer optional supplements, your own qualified coaching, and memberships. WellStaq takes 0% of your sales. Lab, clinical, pharmacy, product, and operating costs are separate; clinical fees and any management arrangements must follow applicable rules. No prescription commissions or earnings are promised.
Where this fits
Frequently asked questions
Does the genetic report diagnose anything?
No. It is an educational, wellness roadmap that maps variants to pathways for discussion with a licensed provider. It does not diagnose, prescribe, or determine which products anyone should use.
Can we market this as anti-aging?
We avoid anti-aging cure or disease claims. Position it as a premium, data-driven, provider-guided wellness program.
Build your premium tier on data and your brand
Save $700/month — $8,400/year. The first 100 Early Adopters to sign up get $297/mo locked in for life, instead of standard $997/mo. Join the free waitlist for your invitation when enrollment opens.
$0 to start$0 until you're liveno cardcancel anytime
WellStaq provides white-label telehealth technology and brand infrastructure, not medical care. Independent licensed providers make clinical and prescribing decisions. Eligible 503A pharmacy services require a valid patient-specific prescription and compliance with applicable requirements; availability varies. Compounded drugs are not FDA-approved. Provider and pharmacy identities remain disclosed. Health data is used only for permitted purposes with required safeguards and authorizations. Billing, marketing, privacy, and management arrangements need state-specific legal review. No health or earnings outcome is guaranteed.